Capability

biomarker detection

Suppliers: 2
States & provinces: 2
Countries: 1

2 biomarker detection suppliers across 2 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

Amprion is a diagnostics company focused on neurodegenerative disorders. It offers the SAAmplify-αSYN Plus seed amplification assay, described as the first clinically available, validated test that detects pathological α-synuclein in CSF with autopsy-confirmed accuracy for diseases such as Parkinson's, Lewy body dementia, multiple system atrophy, and Alzheimer's. The company was founded in 2014 and operates a CAP-accredited and CLIA-certified clinical laboratory in San Diego, California.

clinical laboratory testingCSF testingpatient stratification for clinical trialsseed amplification assay (SAA)skin biopsy testing

Gamma Diagnostics is the global expert in Gamma Prime Fibrinogen (GPF), a biomarker for predicting clotting and inflammation in cardiovascular disease and other conditions such as COVID-19. Founder Dr. David Farrell and his team discovered GPF in 2010. The company offers the GammaCoeur CVD Risk ELISA Test System, a semi-automated quantitative ELISA method for detecting and assessing GPF in human venous plasma samples for clinical and research laboratories.

ELISA testingrisk assessment

Related capabilities

Other processes offered by the shops that list biomarker detection.

clinical laboratory testing (1)
CSF testing (1)
ELISA testing (1)
patient stratification for clinical trials (1)
risk assessment (1)
seed amplification assay (SAA) (1)
skin biopsy testing (1)

Browse all capabilities

biomarker detection

Suppliers

AMPRION, INC.

GAMMA THERAPEUTICS INC

Related capabilities